The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofCoty Inc. (“Coty” or “the Company”) (NYSE: COTY) for violations of the securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. […]

Southwest Gas Holdings, Inc. (NYSE: SWX) (“Southwest Gas Holdings” or the “Company”) today announced the pricing of thepreviously-announced registered public offering ofCenturi Holdings, Inc.(NYSE: CTRI) (“Centuri”) common stock (the “Offering”), pursuant to whichSouthwest Gas Holdings, as the selling stockholder, is offering 27,362,210 existing shares of Centuri's common stock at a price to the public of

The Erie County Prison and their correctional healthcare partner, Armor Health (ArmorHealthcare.com), are pleased to announce the expansion of Medical services to include Mental Health services and Drug and Alcohol Treatment Programs. By administering medications for opioid use disorder (MOUD), this initiative aims to reduce overdose risk and improve overall health outcomes, leveraging national best

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=165164&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / If you suffered a loss on your C3.ai, Inc. (NYSE:AI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/c3-ai-inc-lawsuit-submission-form?prid=165162&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / If you suffered a loss on your PubMatic, Inc. (NASDAQ:PUBM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pubmatic-inc-lawsuit-submission-form?prid=165163&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / If you suffered a loss on your Nutex Health Inc. (NASDAQ:NUTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nutex-health-inc-lawsuit-submission-form?prid=165161&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=165160&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK CITY, NY / ACCESS Newswire / September 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Valneva SE ("Valneva SE") (NASDAQ:VALN) concerning possible violations of federal securities laws. On August 25, 2025, before the market opened, Valneva announced that the FDA suspended the license for its chikungunya

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / If you suffered a loss on your RxSight, Inc. (NASDAQ:RXST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=165158&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call